Neural control of cardiovascular function US Medical PG Practice Questions and MCQs
Practice US Medical PG questions for Neural control of cardiovascular function. These multiple choice questions (MCQs) cover important concepts and help you prepare for your exams.
Neural control of cardiovascular function US Medical PG Question 1: Which receptor type mediates the slow phase of synaptic transmission in autonomic ganglia?
- A. Muscarinic (M3)
- B. Muscarinic (M2)
- C. Muscarinic (M1) (Correct Answer)
- D. Nicotinic (N2)
Neural control of cardiovascular function Explanation: ***Muscarinic (M1)***
- **M1 receptors** are **Gq-protein coupled receptors** that activate phospholipase C, leading to increased intracellular calcium and diacylglycerol, which mediates the slow excitatory postsynaptic potential in autonomic ganglia.
- This activation results in a **slow depolarization** that prolongs the excitability of ganglionic neurons after the initial fast synaptic transmission.
*Muscarinic (M3)*
- **M3 receptors** are primarily found on **smooth muscle**, glands, and endothelium, mediating contraction, secretion, and vasodilation, respectively.
- While also **Gq-protein coupled**, their role in autonomic ganglia is not the main mediator of the slow phase of synaptic transmission.
*Muscarinic (M2)*
- **M2 receptors** are **Gi-protein coupled receptors** mainly found in the heart, mediating decreased heart rate and contractility.
- In autonomic ganglia, M2 receptors could have a modulatory role, but they are not responsible for the slow excitatory phase of synaptic transmission.
*Nicotinic (N2)*
- **Nicotinic N2 receptors** (also known as **NN or neuronal nicotinic receptors**) mediate the **fast excitatory postsynaptic potential** (EPSP) in autonomic ganglia by opening ion channels.
- This leads to rapid depolarization and action potential generation, which is distinct from the **slower, prolonged phase** of transmission.
Neural control of cardiovascular function US Medical PG Question 2: A 33-year-old man presents to the emergency department after an episode of syncope. He states that for the past month ever since starting a new job he has experienced an episode of syncope or near-syncope every morning while he is getting dressed. The patient states that he now gets dressed, shaves, and puts on his tie sitting down to avoid falling when he faints. He has never had this before and is concerned it is stress from his new job as he has been unemployed for the past 5 years. He is wondering if he can get a note for work since he was unable to head in today secondary to his presentation. The patient has no significant past medical history and is otherwise healthy. His temperature is 99.2°F (37.3°C), blood pressure is 122/83 mmHg, pulse is 92/min, respirations are 16/min, and oxygen saturation is 100% on room air. Cardiopulmonary and neurologic exams are within normal limits. An initial ECG and laboratory values are unremarkable as well. Which of the following is the most likely diagnosis?
- A. Malingering
- B. Hypertrophic obstructive cardiomyopathy
- C. Aortic stenosis
- D. Carotid hypersensitivity syndrome (Correct Answer)
- E. Anxiety
Neural control of cardiovascular function Explanation: ***Carotid hypersensitivity syndrome***
- This patient's symptoms of recurrent syncope/near-syncope during activities like **shaving or putting on a tie**, which involve pressure on the neck where the **carotid sinus** is located, are classic for carotid sinus hypersensitivity.
- The maneuvers he is taking to avoid falling (getting dressed, shaving, and putting on his tie while sitting down) further support this diagnosis, as they show an adaptive behavior to a precise, reproducible trigger.
*Malingering*
- While the patient's request for a work note might raise some suspicion, there are **clear, physiologically plausible triggers** for his syncope, and his adaptive behavior suggests a genuine effort to cope with real symptoms rather than feigning illness for external gain.
- Malingering would typically involve less specific or consistent symptoms, and often a more overt attempt to obtain a specific outcome (e.g., disability benefits) without the accompanying adaptive behaviors seen here.
*Hypertrophic obstructive cardiomyopathy*
- This condition can cause exertional syncope due to outflow tract obstruction, but it's less likely to present with syncope triggered by distinct neck maneuvers like **shaving or tying a tie**.
- An initial **ECG and physical exam** would likely show abnormalities (e.g., prominent S waves in V1-V3, left ventricular hypertrophy, murmur) which are absent in this case.
*Aortic stenosis*
- Syncope in aortic stenosis is typically **exertional** and caused by reduced cerebral perfusion during physical activity, not by specific neck movements.
- Aortic stenosis would also likely present with a **characteristic systolic ejection murmur** and ECG changes that were not noted in this otherwise healthy patient, and is less common in a 33-year-old without other risk factors.
*Anxiety*
- While anxiety can cause symptoms like lightheadedness or hyperventilation leading to near-syncope, it typically does not cause **true syncope with loss of consciousness** with such a consistent and specific trigger (neck compression).
- The regular daily occurrence tied to specific actions and the body's physiological response points away from anxiety as the primary cause for the syncope itself, although anxiety about the events could be secondary.
Neural control of cardiovascular function US Medical PG Question 3: A 19-year-old man presents to the clinic with a complaint of increasing shortness of breath for the past 2 years. His shortness of breath is associated with mild chest pain and occasional syncopal attacks during strenuous activity. There is no history of significant illness in the past, however, one of his uncles had similar symptoms when he was his age and died while playing basketball a few years later. He denies alcohol use, tobacco consumption, and the use of recreational drugs. On examination, pulse rate is 76/min and is regular and bounding; blood pressure is 130/70 mm Hg. A triple apical impulse is observed on the precordium and a systolic ejection crescendo-decrescendo murmur is audible between the apex and the left sternal border along with a prominent fourth heart sound. The physician then asks the patient to take a deep breath, close his mouth, and pinch his nose and try to breathe out without allowing his cheeks to bulge out. In doing so, the intensity of the murmur increases. Which of the following hemodynamic changes would be observed first during this maneuver?
- A. ↓ Mean Arterial Pressure, ↑ Heart rate, ↑ Baroreceptor activity, ↓ Parasympathetic Outflow
- B. ↑ Mean Arterial Pressure, ↓ Heart rate, ↑ Baroreceptor activity, ↑ Parasympathetic Outflow (Correct Answer)
- C. ↑ Mean Arterial Pressure, ↓ Heart rate, ↓ Baroreceptor activity, ↑ Parasympathetic Outflow
- D. ↑ Mean Arterial Pressure, ↑ Heart rate, ↓ Baroreceptor activity, ↓ Parasympathetic Outflow
- E. ↑ Mean Arterial Pressure, ↑ Heart rate, ↑ Baroreceptor activity, ↑ Parasympathetic Outflow
Neural control of cardiovascular function Explanation: **↑ Mean Arterial Pressure, ↓ Heart rate, ↑ Baroreceptor activity, ↑ Parasympathetic Outflow**
- This maneuver is the **Valsalva Maneuver**, which involves forced expiration against a closed glottis. It causes a transient increase in **intrathoracic pressure**, compressing the great vessels and temporarily increasing **mean arterial pressure**.
- The initial rise in blood pressure is detected by **baroreceptors**, leading to a reflex decrease in **heart rate** via increased **parasympathetic outflow**.
*↓ Mean Arterial Pressure, ↑ Heart rate, ↑ Baroreceptor activity, ↓ Parasympathetic Outflow*
- This option describes changes more typical of the **later phases** of a Valsalva maneuver (Phase 2), where venous return and cardiac output decrease, leading to a fall in MAP and a compensatory increase in heart rate.
- It does not represent the **immediate hemodynamic changes** (Phase 1) that occur during the initial strain of the maneuver.
*↑ Mean Arterial Pressure, ↓ Heart rate, ↓ Baroreceptor activity, ↑ Parasympathetic Outflow*
- A decrease in **baroreceptor activity** would typically lead to an *increase* in heart rate and a *decrease* in parasympathetic outflow, contrary to the initial response to increased blood pressure.
- The initial increase in MAP correctly leads to *increased* baroreceptor activity.
*↑ Mean Arterial Pressure, ↑ Heart rate, ↓ Baroreceptor activity, ↓ Parasympathetic Outflow*
- An increase in **mean arterial pressure** (MAP) would reflexively cause a *decrease* in heart rate and an *increase* in parasympathetic outflow, mediated by *increased* baroreceptor activity, not decreased activity.
- Therefore, the proposed changes in heart rate, baroreceptor activity, and parasympathetic outflow are inconsistent with an initial increase in MAP.
*↑ Mean Arterial Pressure, ↑ Heart rate, ↑ Baroreceptor activity, ↑ Parasympathetic Outflow*
- While an increase in **mean arterial pressure** does lead to an increase in **baroreceptor activity** and **parasympathetic outflow**, the reflexive response to this increased pressure is a *decrease* in **heart rate**, not an increase.
- An increased heart rate combined with increased parasympathetic outflow is contradictory, as sympathetic and parasympathetic systems typically exert opposing effects on heart rate.
Neural control of cardiovascular function US Medical PG Question 4: A 55-year-old woman comes to the physician because of involuntary hand movements that improve with alcohol consumption. Physical examination shows bilateral hand tremors that worsen when the patient is asked to extend her arms out in front of her. The physician prescribes a medication that is associated with an increased risk of bronchospasms. This drug has which of the following immediate effects on the cardiovascular system?
Stroke volume | Heart rate | Peripheral vascular resistance
- A. ↓ ↓ ↓
- B. ↓ ↓ ↑ (Correct Answer)
- C. ↓ ↑ ↑
- D. ↑ ↑ ↑
- E. ↑ ↑ ↓
Neural control of cardiovascular function Explanation: ***↓ ↓ ↑***
- This patient likely has **essential tremor**, which is characterized by **bilateral hand tremors** that improve with alcohol and worsen with intention (postural tremor). The prescribed medication is a **beta-blocker** (e.g., propranolol), which is associated with an increased risk of bronchospasms due to blocking **beta-2 receptors** in the airways.
- Beta-blockers **decrease heart rate** (negative chronotropic effect) and **stroke volume** (negative inotropic effect) by blocking beta-1 receptors in the heart, reducing cardiac output.
- **Peripheral vascular resistance increases** acutely due to: (1) **unopposed alpha-1 adrenergic tone** in blood vessels (loss of beta-2 mediated vasodilation), and (2) baroreceptor-mediated reflex vasoconstriction in response to decreased cardiac output. This helps maintain blood pressure despite reduced cardiac output.
*↓ ↓ ↓*
- While beta-blockers decrease **heart rate** and **stroke volume**, peripheral vascular resistance does not decrease acutely. A decrease in all three parameters would cause severe hypotension.
- The loss of beta-2 receptor-mediated vasodilation and baroreceptor reflexes lead to increased, not decreased, peripheral vascular resistance.
*↓ ↑ ↑*
- Beta-blockers **decrease heart rate** through beta-1 blockade, not increase it. This is their primary cardiac mechanism of action.
- An increase in heart rate would be expected with sympathomimetic drugs or anticholinergics, not beta-blockers.
*↑ ↑ ↑*
- This combination indicates increased cardiovascular activity, which is the opposite effect of **beta-blockers**.
- Beta-blockers reduce heart rate and stroke volume by blocking beta-1 receptors; they do not increase these parameters.
- This pattern would suggest sympathetic activation or administration of an adrenergic agonist.
*↑ ↑ ↓*
- Beta-blockers **decrease** (not increase) both heart rate and stroke volume through beta-1 receptor blockade.
- While decreased peripheral vascular resistance occurs with vasodilators, beta-blockers acutely **increase** PVR due to unopposed alpha-adrenergic tone.
Neural control of cardiovascular function US Medical PG Question 5: A 60-year-old male engineer who complains of shortness of breath when walking a few blocks undergoes a cardiac stress test because of concern for coronary artery disease. During the test he asks his cardiologist about what variables are usually used to quantify the functioning of the heart. He learns that one of these variables is stroke volume. Which of the following scenarios would be most likely to lead to a decrease in stroke volume?
- A. Anxiety
- B. Heart failure (Correct Answer)
- C. Exercise
- D. Pregnancy
- E. Digitalis
Neural control of cardiovascular function Explanation: ***Heart failure***
- In **heart failure**, the heart's pumping ability is impaired, leading to a reduced **ejection fraction** and thus a decreased **stroke volume**.
- The weakened myocardium cannot effectively contract to expel the normal volume of blood, resulting in lower blood output per beat.
*Anxiety*
- **Anxiety** typically causes an increase in **sympathetic nervous system** activity, leading to increased heart rate and myocardial contractility.
- This often results in a temporary **increase in stroke volume** due to enhanced cardiac performance, not a decrease.
*Exercise*
- During **exercise**, there is a significant **increase in venous return** and sympathetic stimulation, leading to increased **end-diastolic volume** and contractility.
- This physiological response causes a substantial **increase in stroke volume** to meet the body's higher oxygen demands.
*Pregnancy*
- **Pregnancy** leads to significant **physiological adaptations** to accommodate the growing fetus, including a substantial increase in **blood volume**.
- This increased blood volume and cardiac output result in an **increase in stroke volume** to maintain adequate perfusion for both mother and fetus.
*Digitalis*
- **Digitalis** is a cardiac glycoside that **increases intracellular calcium** in myocardial cells, enhancing the **force of contraction**.
- This positive inotropic effect leads to an **increased stroke volume** by improving the heart's pumping efficiency.
Neural control of cardiovascular function US Medical PG Question 6: A 32-year-old woman comes to the physician for a screening health examination that is required for scuba diving certification. The physician asks her to perform a breathing technique: following deep inspiration, she is instructed to forcefully exhale against a closed airway and contract her abdominal muscles while different cardiovascular parameters are evaluated. Which of the following effects is most likely after 10 seconds in this position?
- A. Decreased intra-abdominal pressure
- B. Decreased left ventricular stroke volume (Correct Answer)
- C. Decreased pulse rate
- D. Decreased systemic vascular resistance
- E. Increased venous return to left atrium
Neural control of cardiovascular function Explanation: ***Decreased left ventricular stroke volume***
- After 10 seconds of performing the **Valsalva maneuver**, the increased intrathoracic pressure significantly reduces **venous return** to the heart.
- Reduced venous return leads to decreased **ventricular filling** (preload), which in turn diminishes **left ventricular stroke volume** and cardiac output.
*Decreased intra-abdominal pressure*
- The instruction to "contract her abdominal muscles" during forceful exhalation against a closed airway (Valsalva maneuver) directly leads to an **increase** in **intra-abdominal pressure**, not a decrease.
- This increase in intra-abdominal pressure further impedes venous return from the lower extremities to the heart.
*Decreased pulse rate*
- In the initial phase of the Valsalva maneuver (first 5-10 seconds), the decrease in cardiac output triggers a **reflex tachycardia** to maintain blood pressure, leading to an **increased pulse rate**.
- A decrease in pulse rate (bradycardia) is more characteristic of the release phase, not during the sustained strain.
*Decreased systemic vascular resistance*
- During the Valsalva maneuver, the body attempts to compensate for the drop in cardiac output and blood pressure by increasing **sympathetic tone**, which causes **vasoconstriction** and thus **increases systemic vascular resistance**.
- A decrease in systemic vascular resistance would further drop blood pressure and is not the physiological response during this phase.
*Increased venous return to left atrium*
- The Valsalva maneuver dramatically **reduces venous return** to both the right and left atria due to the high intrathoracic pressure compressing the great veins.
- This decreased venous return is the primary mechanism leading to the subsequent fall in cardiac output during the maneuver.
Neural control of cardiovascular function US Medical PG Question 7: A 27-year-old woman G2P1 at 34 weeks estimated gestational age presents with bouts of sweating, weakness, and dizziness lasting a few minutes after lying down on the bed. She says symptoms resolve if she rolls on her side. She reports that these episodes have occurred several times over the last 3 weeks. On lying down, her blood pressure is 90/50 mm Hg and her pulse is 50/min. When she rolls on her side, her blood pressure slowly increases to 120/65 mm Hg, and her pulse increases to 72/min. Which of the following best describes the mechanism which underlies this patient’s most likely condition?
- A. Peripheral vasodilation
- B. Increase in plasma volume
- C. Progesterone surge
- D. Renin-angiotensin system activation
- E. Aortocaval compression (Correct Answer)
Neural control of cardiovascular function Explanation: ***Aortocaval compression***
- This condition, also known as **supine hypotensive syndrome**, occurs when the gravid uterus **compresses the inferior vena cava (IVC)** and potentially the aorta, reducing **venous return** to the heart.
- The symptoms (sweating, weakness, dizziness, hypotension, bradycardia) and their resolution upon changing position are classic signs of reduced cardiac output due to IVC compression.
*Peripheral vasodilation*
- While **peripheral vasodilation** does occur in pregnancy due to hormonal changes, it generally contributes to a **mild decrease in systemic vascular resistance** and is not the primary mechanism behind acute, position-dependent hypotensive episodes.
- It would not explain the sudden, severe symptoms that resolve promptly with a change in position, nor the associated bradycardia which is more indicative of a **vasovagal response** to decreased cardiac filling.
*Increase in plasma volume*
- Pregnancy is associated with a significant **increase in plasma volume** (up to 50%), which is a physiological adaptation to support the uteroplacental unit.
- An increase in plasma volume would generally help **maintain blood pressure** and prevent hypotension, rather than causing the specific symptoms described in this patient.
*Progesterone surge*
- **Progesterone levels do increase significantly** during pregnancy and contribute to **smooth muscle relaxation**, which can lead to vasodilation.
- However, a progesterone surge itself does not directly cause acute, position-dependent hypotensive episodes; its vasodilatory effects are more chronic and physiological.
*Renin-angiotensin system activation*
- The **renin-angiotensin system (RAS) is typically activated** and upregulated during pregnancy, contributing to fluid balance and blood pressure regulation.
- Activation of the RAS would generally lead to **vasoconstriction and increased blood pressure**, not the hypotensive episodes observed in this patient.
Neural control of cardiovascular function US Medical PG Question 8: A 22-year-old man presents with a history of lightheadedness, weakness, and palpitations when he assumes an upright position from a supine position. He is otherwise a healthy man without a history of alcohol or other substance abuse. His supine and standing blood pressures (measured at 3-minute intervals) were 124/82 mm Hg and 102/72 mm Hg, respectively. He was advised to perform a Valsalva maneuver while monitoring blood pressure and heart rate to assess the integrity of his baroreflex control. Which of the following statements is correct?
- A. During early phase II, there is an increase in blood pressure and a decrease in heart rate
- B. Phases III and IV are mediated by baroreceptor reflexes that require intact efferent parasympathetic responses
- C. During phase I, the blood pressure decreases due to increased intrathoracic pressure
- D. During late phase II, there is an increase in both blood pressure and heart rate (Correct Answer)
- E. The Valsalva ratio is defined as the maximum phase II tachycardia divided by the minimum phase IV bradycardia
Neural control of cardiovascular function Explanation: ***During late phase II, there is an increase in both blood pressure and heart rate***
- In **late phase II** of the Valsalva maneuver, the sustained intrathoracic pressure reduces venous return, leading to a compensatory **increase in heart rate** and **peripheral vasoconstriction** via baroreflex stimulation, which aims to normalize cardiac output and blood pressure.
- While cardiac output remains low, the increased peripheral resistance causes the **blood pressure to rise** back towards baseline, or even slightly above, as the body struggles to maintain perfusion.
*The Valsalva ratio is defined as the maximum phase II tachycardia divided by the minimum phase IV bradycardia*
- The **Valsalva ratio** is defined as the maximum R-R interval during phase IV (bradycardia) divided by the minimum R-R interval during phase II (tachycardia) of the maneuver.
- This ratio primarily assesses **parasympathetic function** and is used to evaluate autonomic neuropathy.
- The option incorrectly reverses the physiological responses: phase II is characterized by **tachycardia** (not bradycardia) and phase IV by **bradycardia** (not tachycardia).
*During early phase II, there is an increase in blood pressure and a decrease in heart rate*
- In **early phase II**, the sustained intrathoracic pressure significantly **reduces venous return** and subsequently **cardiac output**, which leads to a noticeable **drop in blood pressure**.
- This drop in blood pressure activates the baroreflex, causing a compensatory **increase in heart rate**, not a decrease.
*Phases III and IV are mediated by baroreceptor reflexes that require intact efferent parasympathetic responses*
- **Phase III** is primarily a mechanical event where release of intrathoracic pressure causes an immediate drop in blood pressure as the aorta re-expands; this does not specifically require parasympathetic responses.
- **Phase IV** involves baroreceptor-mediated **parasympathetic activation** causing reflex bradycardia as blood pressure overshoots baseline due to increased venous return combined with persistent vasoconstriction.
- The statement is imprecise as it applies primarily to phase IV, not phase III.
*During phase I, the blood pressure decreases due to increased intrathoracic pressure*
- **Phase I** begins with the onset of straining and **increased intrathoracic pressure**, which briefly **compresses the aorta** and large arteries, causing a **transient increase in blood pressure**.
- This initial rise in pressure is due to mechanical compression, not a decrease.
Neural control of cardiovascular function US Medical PG Question 9: A 33-year-old female presents to her primary care physician complaining of heat intolerance and difficulty sleeping over a one month period. She also reports that she has lost 10 pounds despite no changes in her diet or exercise pattern. More recently, she has developed occasional unprovoked chest pain and palpitations. Physical examination reveals a nontender, mildly enlarged thyroid gland. Her patellar reflexes are 3+ bilaterally. Her temperature is 99°F (37.2°C), blood pressure is 135/85 mmHg, pulse is 105/min, and respirations are 18/min. Laboratory analysis is notable for decreased TSH. Which of the following pathophysiologic mechanisms contributed to the cardiovascular symptoms seen in this patient?
- A. Increased numbers of α1-adrenergic receptors
- B. Increased sensitivity of β1-adrenergic receptors (Correct Answer)
- C. Decreased numbers of α2-adrenergic receptors
- D. Decreased sensitivity of β2-adrenergic receptors
- E. Decreased numbers of α1-adrenergic receptors
Neural control of cardiovascular function Explanation: ***Increased sensitivity of β1-adrenergic receptors***
- Elevated thyroid hormone levels in **hyperthyroidism** increase the expression and sensitivity of **β1-adrenergic receptors** in the heart.
- This heightened sensitivity leads to an exaggerated response to **catecholamines**, contributing to symptoms like **tachycardia**, **palpitations**, and **chest pain**.
*Increased numbers of α1-adrenergic receptors*
- While thyroid hormones can influence adrenergic receptor expression, the primary cardiovascular effects of hyperthyroidism are mediated by **β-adrenergic receptors**, not α1.
- An increase in α1-adrenergic receptors would primarily lead to **vasoconstriction**, which is not the predominant cardiovascular pathology in hyperthyroidism where **increased heart rate** and contractility are key.
*Decreased numbers of α1-adrenergic receptors*
- This would generally lead to **vasodilation** and possibly hypotension, which is contrary to the **palpitations** and **chest pain** seen in the patient's hyperthyroid state.
- Hyperthyroidism tends to increase cardiac output and contractility rather than decrease peripheral resistance through reduced α1 receptors.
*Decreased numbers of α2-adrenergic receptors*
- **Alpha-2 adrenergic receptors** are often involved in **negative feedback** to reduce sympathetic outflow from the central nervous system.
- A decrease in these receptors would theoretically increase sympathetic activity, but the direct cardiovascular effects in hyperthyroidism are primarily due to altered **β-adrenergic receptor** function.
*Decreased sensitivity of β2-adrenergic receptors*
- **Beta-2 adrenergic receptors** are primarily found in smooth muscle (e.g., bronchioles, blood vessels) and mediate **vasodilation and bronchodilation**.
- Decreased sensitivity would lead to **vasoconstriction** and **bronchoconstriction**, which are not characteristic cardiovascular or pulmonary findings in hyperthyroidism.
Neural control of cardiovascular function US Medical PG Question 10: A researcher is studying receptors that respond to epinephrine in the body and discovers a particular subset that is expressed in presynaptic adrenergic nerve terminals. She discovers that upon activation, these receptors will lead to decreased sympathetic nervous system activity. She then studies the intracellular second messenger changes that occur when this receptor is activated. She records these changes and begins searching for analogous receptor pathways. Which of the following receptors would cause the most similar set of intracellular second messenger changes?
- A. Muscarinic cholinoreceptors in the gastrointestinal tract
- B. Growth hormone receptors in the musculoskeletal system
- C. Vasopressin receptors in the kidney
- D. Dopamine receptors in the brain (Correct Answer)
- E. Aldosterone receptors in the kidney
Neural control of cardiovascular function Explanation: ***Dopamine receptors in the brain***
- The described presynaptic receptors for epinephrine that decrease sympathetic activity are **alpha-2 adrenergic receptors**, which are **G inhibitory protein (Gi)-coupled receptors**.
- Gi-coupled receptors **inhibit adenylyl cyclase**, leading to a **decrease in intracellular cAMP**, a signaling pathway shared by **D2 dopamine receptors**.
*Muscarinic cholinoreceptors in the gastrointestinal tract*
- Most muscarinic receptors (M1 and M3) in the GI tract are **Gq-coupled**, leading to an **increase in phospholipase C (PLC) activity**, ultimately increasing intracellular **IP3 and DAG** and promoting smooth muscle contraction.
- This mechanism is distinct from the **Gi-mediated inhibition of cAMP** described for the presynaptic adrenergic receptor.
*Growth hormone receptors in the musculoskeletal system*
- Growth hormone receptors are **tyrosine kinase-associated receptors** (specifically, they are linked to **JAK/STAT pathways**), not G protein-coupled receptors.
- Their intracellular signaling involves **protein phosphorylation cascades**, which are fundamentally different from second messenger changes involving cAMP.
*Vasopressin receptors in the kidney*
- Vasopressin (ADH) acts on **V2 receptors** in the kidney, which are **G stimulatory protein (Gs)-coupled receptors**.
- Activation of V2 receptors leads to an **increase in adenylyl cyclase activity** and thus an **increase in intracellular cAMP**, the opposite effect of the described Gi-coupled receptor.
*Aldosterone receptors in the kidney*
- Aldosterone receptors are **intracellular steroid hormone receptors** that directly bind to DNA and regulate gene transcription.
- They do not engage in rapid intracellular second messenger changes like G protein-coupled receptors, but rather alter **protein synthesis** over hours to days.
More Neural control of cardiovascular function US Medical PG questions available in the OnCourse app. Practice MCQs, flashcards, and get detailed explanations.
